Unique Evolution of Antiviral Tetherin in Bats. 2022

Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
Health Security Program, Life Sciences Discipline, Burnet Institutegrid.1056.2, Melbourne, Victoria, Australia.

Bats are recognized as important reservoirs of viruses deadly to other mammals, including humans. These infections are typically nonpathogenic in bats, raising questions about host response differences that might exist between bats and other mammals. Tetherin is a restriction factor which inhibits the release of a diverse range of viruses from host cells, including retroviruses, coronaviruses, filoviruses, and paramyxoviruses, some of which are deadly to humans and transmitted by bats. Here, we characterize the tetherin genes from 27 bat species, revealing that they have evolved under strong selective pressure, and that fruit bats and vesper bats express unique structural variants of the tetherin protein. Tetherin was widely and variably expressed across fruit bat tissue types and upregulated in spleen tissue when stimulated with Toll-like receptor agonists. The expression of two computationally predicted splice isoforms of fruit bat tetherin was verified. We identified an additional third unique splice isoform which includes a C-terminal region that is not homologous to known mammalian tetherin variants but was functionally capable of restricting the release of filoviral virus-like particles. We also report that vesper bats possess and express at least five tetherin genes, including structural variants, more than any other mammal reported to date. These findings support the hypothesis of differential antiviral gene evolution in bats relative to other mammals. IMPORTANCE Bats are an important host of various viruses which are deadly to humans and other mammals but do not cause outward signs of illness in bats. Furthering our understanding of the unique features of the immune system of bats will shed light on how they tolerate viral infections, potentially informing novel antiviral strategies in humans and other animals. This study examines the antiviral protein tetherin, which prevents viral particles from escaping their host cell. Analysis of tetherin from 27 bat species reveals that it is under strong evolutionary pressure, and we show that multiple bat species have evolved to possess more tetherin genes than other mammals, some of which encode structurally unique tetherins capable of activity against different viral particles. These data suggest that bat tetherin plays a potentially broad and important role in the management of viral infections in bats.

UI MeSH Term Description Entries
D002685 Chiroptera Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats. Bats,Flying Foxes,Horseshoe Bats,Pteropodidae,Pteropus,Rhinolophus,Rousettus,Bat, Horseshoe,Bats, Horseshoe,Foxes, Flying,Horseshoe Bat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074010 Bone Marrow Stromal Antigen 2 A GPI-linked membrane glycoprotein and antiviral factor that functions as a homodimer. It is induced by INTERFERON-GAMMA and blocks the release of enveloped mammalian viruses by directly tethering nascent VIRAL PARTICLES to the membranes of infected cells. Antigen, CD317,Antigens, CD317,Bone Marrow Stromal Cell Antigen 2,CD317 Antigen,Tetherin,CD317 Antigens
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D014780 Viruses Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. Animal Viruses,Zoophaginae,Animal Virus,Virus,Virus, Animal,Viruses, Animal
D051193 Toll-Like Receptors A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS. Receptors, Toll-Like,Toll-Like Receptor,Receptor, Toll-Like,Receptors, Toll Like,Toll Like Receptor,Toll Like Receptors

Related Publications

Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
July 2010, PloS one,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
August 2016, Cell host & microbe,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
January 2013, Current topics in microbiology and immunology,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
January 2010, Bing du xue bao = Chinese journal of virology,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
January 1972, Parazitologiia,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
May 2019, Reviews in medical virology,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
December 2009, AIDS research and human retroviruses,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
December 2020, Immunity,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
January 2023, Frontiers in cellular and infection microbiology,
Joshua A Hayward, and Mary Tachedjian, and Adam Johnson, and Aaron T Irving, and Tamsin B Gordon, and Jie Cui, and Alexis Nicolas, and Ina Smith, and Victoria Boyd, and Glenn A Marsh, and Michelle L Baker, and Lin-Fa Wang, and Gilda Tachedjian
December 2015, Journal of virology,
Copied contents to your clipboard!